Understanding Variation in Sets of N-of-1 Trials.

by Artur Araujo, Steven Julious, Stephen Senn
Published 2016-01-01

How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis

by Laura Flight, Steven Julious, Alan Brennan, Susan Todd, Daniel Hind
Published 2020-03-01

Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project

by Nikki Totton, Steven Julious, Dyfrig Hughes, Jonathan Cook, Katie Biggs, Lizzie Coates, Andrew Cook, Catherine Hewitt, Simon Day
Published 2021-01-01

Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlle...

by Dinesh Selvarajah, Jennifer Petrie, David White, Steven Julious, Oscar Bortolami, Cindy Cooper, Mike Bradburn, Amanda Loban, Helen Bowler, Lizzie Swaby, Katie Sutherland, Solomon Tesfaye, on behalf of the OPTION-DM group
Published 2018-10-01

Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT

by Rebecca Palmer, Munyaradzi Dimairo, Nicholas Latimer, Elizabeth Cross, Marian Brady, Pam Enderby, Audrey Bowen, Steven Julious, Madeleine Harrison, Abualbishr Alshreef, Ellen Bradley, Arjun Bhadhuri, Tim Chater, Helen Hughes, Helen Witts, Esther Herbert, Cindy Cooper
Published 2020-04-01